Adiponectin and renal disease progression: another epidemiologic conundrum?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17554349.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In an analysis based on the Mild to Moderate Kidney Disease (MMKD) study, adiponectin, a pleiotropic, insulin-sensitizing, anti-inflammatory and vasculo-protective cytokine, was directly related to renal disease progression. The precise definition of this apparently paradoxical association now requires that the research focus be moved from the study database to the experimental laboratory.
Medical subject headings
- Adiponectin
- Kidney Diseases